Putting stem cells at the heart of predictive drug toxicity testing
(WorldNews Environment)

By Kevin Moore In the pharmaceutical industry, stem cells play a growing role in all phases of drug discovery, from disease modeling and early target discovery to their use in developing innovative cell therapies. Increasingly, a major development impact factor for stem cells is their capacity to serve as a self-renewing, sustainable source of differentiated cell models to support predictive toxicity testing in early stage drug discovery. Tecan will address an important technology aspect of using stem cells for drug discovery an in upcoming webinar on May 22nd 2018. This informative webinar will describe and discuss the use of automation for high-throughput screening to enable unattended...